title: [Epidemiology of Clostridium difficile infection in Spain].
abstract: There has been increasing interest in Clostridium difficile infection (CDI) due its association with healthcare and its impact on morbidity and mortality in the elderly. During the last few years there has been a growing increase in the number of published studies on the incidence, changes on the clinical presentation and on the epidemiology, with the description of new risk factors. The frequency of CDI in Spain is not sufficiently characterised. The available data indicates that incidence is within the range of that of surrounding countries but increasing. Furthermore, the high and growing use of broad spectrum antibiotics, both in our hospitals and in the community setting, are factors that favour the increase of the disease. The hyper-virulent ribotype 027 has not spread in our hospitals. We need to know with enhanced validity and accuracy the incidence of CDI, both community and healthcare-associated, the information on outbreaks, the incidence on certain population groups, the characterisation of circulating ribotypes and the impact of the disease in terms of mortality and health costs. We need to implement programs for the improvement of antibiotic therapy in the hospital, as well as in the community. Furthermore, the knowledge and the performance of standard precautions need to be improved, particularly hand hygiene, and the specific measures to limit the transmission of C. difficile among the healthcare institutions.
authors.affiliation: Servicio de Medicina Preventiva, Hospital Universitario Puerta de Hierro, Majadahonda, Madrid, España. aasensio.hpth@salud.madrid.org
authors.forename: Angel
authors.initials: A
authors.lastname: Asensio
authors.forename: Diana
authors.initials: D
authors.lastname: Monge
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D016360:Clostridioides difficile / Q000187:drug effects / Q000302:isolation & purification / Q000472:pathogenicity; D003015:Clostridium Infections / Q000191:economics / Q000453:epidemiology* / Q000382:microbiology / Q000517:prevention & control / Q000635:transmission; D017714:Community-Acquired Infections / Q000453:epidemiology / Q000382:microbiology / Q000517:prevention & control / Q000635:transmission; D003365:Costs and Cost Analysis; D003428:Cross Infection / Q000453:epidemiology / Q000382:microbiology / Q000517:prevention & control / Q000635:transmission; D004196:Disease Outbreaks; D004352:Drug Resistance, Microbial; D006801:Humans; D015994:Incidence; D009017:Morbidity / Q000639:trends; D015995:Prevalence; D021521:Ribotyping; D012307:Risk Factors; D013030:Spain / Q000453:epidemiology; D016635:Universal Precautions; D014774:Virulence
chemical_list: D000900:Anti-Bacterial Agents